5th Oligonucleotides for CNS Summit

Hits:136   Date: 5/28/2025

August 27-29, 2025 | Boston, MA

 
About the Event:
The 5th Oligonucleotides for CNS Summit unites a select group of industry-leading biologists, chemists, C-level executives, platform tech experts, DMPK and clinical pharmacologists, all tackling the unique challenges of CNS delivered ASOs, siRNAs, miRNAs and saRNAs.
 
This August, hear from Alnylam Pharmaceuticals, Denali Therapeutics, Genentech, FDA, Novo Nordisk, Regeneron, Servier, Stoke Therapeutics, Ultragenyx Pharmaceutical and more, to redefine the landscape of oligonucleotide research.
 
What can you expect in 2025?
* Unpublished insights and never-seen-before data
* Two tracked workshop day designed for chemists and biologists
* 10 new presenting companies including Denali Therapeutics, Alnylam Pharmaceuticals and Novo Nordisk
* Regulator presence from Ron Wange, a former FDA expert and author of the non-clinical guidance for oligonucleotides
 
Want to learn more? Access the full event guide here: https://ter.li/g3eg3b
 
contact us:
Michelle Phan
T: +44 (0)20 3141 8700
Email: info@hansonwade.com